Ineffectiveness and toxicity of BCG vaccine for the prevention of recurrent genital herpes.

One hundred fifty-five patients with genital herpes were enrolled in a double-blind, placebo-controlled trial comparing 0.1 ml of intradermal BCG vaccine with placebo for the prevention of recurrent episodes of genital herpes. The mean rate or recurrence over 9 months of prospective follow-up was 0....

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	Antimicrob Agents Chemother
Päätekijät:	Douglas, J M, Vontver, L A, Stamm, W E, Reeves, W C, Critchlow, C, Remington, M L, Holmes, K K, Corey, L
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 1985
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC176238/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3885848/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.2.203
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!